💊 GSK becomes, well, GSK; Otsuka says sayonara to Akebia; GII buys into Almeswak

A $25 million Legacy; HFMD on the rise in Malaysia

Hello there. How’s the week treating you so far? If you’re North Korean, probably not so well.

In today’s Kable: GSK rebrands, does it?; AZ doubles down on Covid antibodies; Eight Roads plots inroads in India; Apollo Global makes a big bet on biotech; Australia has a biotech blueprint; Monkeypox infections in the UK double; Dentists get AI, and nanobots…